title: Development of daptomycin nonsusceptibility with heterogeneous vancomycin-intermediate resistance and oxacillin susceptibility in methicillin-resistant Staphylococcus aureus during high-dose daptomycin treatment.
authors.forename: Chen-Hsiang
authors.initials: CH
authors.lastname: Lee
authors.forename: Ming-Chung
authors.initials: MC
authors.lastname: Wang
authors.forename: I-Wen
authors.initials: IW
authors.lastname: Huang
authors.forename: Feng-Jui
authors.initials: FJ
authors.lastname: Chen
authors.forename: Tsai-Ling
authors.initials: TL
authors.lastname: Lauderdale
mesh_terms: D000081:Acetamides / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017576:Daptomycin / Q000627:therapeutic use*; D006801:Humans; D000069349:Linezolid; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects* / Q000472:pathogenicity*; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010068:Oxacillin / Q000627:therapeutic use*; D023303:Oxazolidinones / Q000627:therapeutic use; D017334:Teicoplanin / Q000627:therapeutic use; D020713:Vancomycin Resistance
chemical_list: D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D017334:Teicoplanin; D000069349:Linezolid; D017576:Daptomycin; D010068:Oxacillin